Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-038451

Director sold 19,565 shares at $15.14 ($296,269)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SCHIFF ANDREW N Director 2022-06-17 Sale −19,565 $15.14 $296,269 0 D
Open-market sales · 19,565 sh · avg $15.14 · $296,269
Loading xslF345X03/doc4.xml…